Emerging Europe

Regional trend analysis, forecasts and market intelligence for the Pharma & Healthcare industry

Latest Emerging Europe Analysis

Industry Trend Analysis - Amgen On Track To Take Lead In Cancer Biosimilar Market - JAN 2018

Having already gained the first US approval for biosimilar bevacizumab, this step towards EU approval further cements Amgen's position as an early leader in the biosimilar market. Amgen, and its partner, Allergan, are on track to have the first marketed cancer biosimilar in both the US and EU, although legal wrangling has so far prevented a US launch. The impact on Roche is likely to be muted...

READ FULL ARTICLE...

Industry Trend Analysis - Healthcare Reforms To Drive Pharmaceutical Spending Growth - NOV 2017

Increasing disease burdens and rising demand for higher quality treatments will place increasing pressures on healthcare systems across the CEE region, posing downside risks to multinational drugmaker opportunities. Many governments will seek to implement reforms to increase spending efficiency or to enable greater access to treatments and the success of which will be a major factor in determin...

READ FULL ARTICLE...